These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

652 related items for PubMed ID: 29027863

  • 1. Potential utility of FLAIR in MRI-negative Cushing's disease.
    Chatain GP, Patronas N, Smirniotopoulos JG, Piazza M, Benzo S, Ray-Chaudhury A, Sharma S, Lodish M, Nieman L, Stratakis CA, Chittiboina P.
    J Neurosurg; 2018 Sep; 129(3):620-628. PubMed ID: 29027863
    [Abstract] [Full Text] [Related]

  • 2. Comparison of MRI techniques for detecting microadenomas in Cushing's disease.
    Grober Y, Grober H, Wintermark M, Jane JA, Oldfield EH.
    J Neurosurg; 2018 Apr; 128(4):1051-1057. PubMed ID: 28452619
    [Abstract] [Full Text] [Related]

  • 3. Volume interpolated 3D-spoiled gradient echo sequence is better than dynamic contrast spin echo sequence for MRI detection of corticotropin secreting pituitary microadenomas.
    Kasaliwal R, Sankhe SS, Lila AR, Budyal SR, Jagtap VS, Sarathi V, Kakade H, Bandgar T, Menon PS, Shah NS.
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):825-30. PubMed ID: 23061773
    [Abstract] [Full Text] [Related]

  • 4. Pituitary tumour localization in patients with Cushing's disease by magnetic resonance imaging. Is there a place for petrosal sinus sampling?
    de Herder WW, Uitterlinden P, Pieterman H, Tanghe HL, Kwekkeboom DJ, Pols HA, Singh R, van de Berge JH, Lamberts SW.
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):87-92. PubMed ID: 8306486
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Outcomes of three-Tesla magnetic resonance imaging for the identification of pituitary adenoma in patients with Cushing's disease.
    Fukuhara N, Inoshita N, Yamaguchi-Okada M, Tatsushima K, Takeshita A, Ito J, Takeuchi Y, Yamada S, Nishioka H.
    Endocr J; 2019 Mar 28; 66(3):259-264. PubMed ID: 30760659
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
    Chittiboina P, Montgomery BK, Millo C, Herscovitch P, Lonser RR.
    J Neurosurg; 2015 Apr 28; 122(4):791-7. PubMed ID: 25479121
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Different imaging characteristics of concurrent pituitary adenomas in a patient with Cushing's disease.
    Mehta GU, Montgomery BK, Raghavan P, Sharma S, Nieman LK, Patronas N, Oldfield EH, Chittiboina P.
    J Clin Neurosci; 2015 May 28; 22(5):891-4. PubMed ID: 25827866
    [Abstract] [Full Text] [Related]

  • 12. Petrosal sinus sampling for diagnosis of Cushing's disease: evidence of false negative results.
    López J, Barceló B, Lucas T, Salame F, Alameda C, Boronat M, Salto L, Estrada J.
    Clin Endocrinol (Oxf); 1996 Aug 28; 45(2):147-56. PubMed ID: 8881446
    [Abstract] [Full Text] [Related]

  • 13. Pituitary magnetic resonance imaging in Cushing's disease.
    Vitale G, Tortora F, Baldelli R, Cocchiara F, Paragliola RM, Sbardella E, Simeoli C, Caranci F, Pivonello R, Colao A, A.B.C. Group.
    Endocrine; 2017 Mar 28; 55(3):691-696. PubMed ID: 27435590
    [Abstract] [Full Text] [Related]

  • 14. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.
    Storr HL, Afshar F, Matson M, Sabin I, Davies KM, Evanson J, Plowman PN, Besser GM, Monson JP, Grossman AB, Savage MO.
    Eur J Endocrinol; 2005 Jun 28; 152(6):825-33. PubMed ID: 15941921
    [Abstract] [Full Text] [Related]

  • 15. Indication to dynamic and invasive testing in Cushing's disease according to different neuroradiological findings.
    Ferrante E, Barbot M, Serban AL, Ceccato F, Carosi G, Lizzul L, Sala E, Daniele A, Indirli R, Cuman M, Locatelli M, Manara R, Arosio M, Boscaro M, Mantovani G, Scaroni C.
    J Endocrinol Invest; 2022 Mar 28; 45(3):629-637. PubMed ID: 34699044
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
    Yap LB, Turner HE, Adams CB, Wass JA.
    Clin Endocrinol (Oxf); 2002 Jan 28; 56(1):25-31. PubMed ID: 11849243
    [Abstract] [Full Text] [Related]

  • 20. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M, Klibanski A.
    J Clin Endocrinol Metab; 1998 May 28; 83(5):1619-23. PubMed ID: 9589666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.